Seer, Inc. (NASDAQ:SEER) Shares Shorted: Short Interest Down 40.1% in September

Seer, Inc. (NASDAQ:SEER) saw a large drop in short interest in the month of September. As of September 15th, there was short interest totaling 87,329 shares, a drop of 40.1% from the August 31st total of 145,773 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average trading volume of 157,532 shares, the short-interest ratio is presently 0.6 days.

Institutional Trading of Seer

Several institutional investors and hedge funds have recently bought and sold shares of SEER. Marquette Asset Management LLC acquired a new stake in shares of Seer during the 2nd quarter worth about $103,000. Corient Private Wealth LP grew its position in Seer by 15.8% during the second quarter. Corient Private Wealth LP now owns 73,200 shares of the company’s stock worth $122,000 after buying an additional 10,000 shares in the last quarter. NewEdge Advisors LLC bought a new stake in shares of Seer during the 1st quarter valued at $132,000. T3 Companies LLC bought a new position in shares of Seer in the fourth quarter worth $242,000. Finally, Rangeley Capital LLC grew its stake in Seer by 821.5% during the first quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock worth $310,000 after buying an additional 164,302 shares in the last quarter. Institutional investors own 75.20% of the company’s stock.

Seer Stock Performance

Shares of SEER stock opened at $2.15 on Wednesday. The firm’s 50 day moving average price is $2.02 and its two-hundred day moving average price is $1.90. The stock has a market cap of $119.33 million, a PE ratio of -1.77 and a beta of 1.50. Seer has a 52-week low of $1.55 and a 52-week high of $2.41.

Seer (NASDAQ:SEER) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($0.31) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.04). Seer had a negative net margin of 478.05% and a negative return on equity of 27.23%. The company had revenue of $3.10 million during the quarter, compared to the consensus estimate of $3.55 million.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Seer in a research report on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $4.00.

About Seer

Seer, Inc is a life sciences technology company that develops tools for large-scale protein analysis, or proteomics. Its platform is designed to help researchers study the proteins present in biological samples, supporting applications in drug discovery, biomarker research, translational research and the development of precision medicine.

The company’s principal offering is the Proteograph Product Suite, which uses proprietary nanoparticle technology to provide broad and rapid access to the proteome.